Sleeptite appoints Tucker head of R & D
Sleeptite has appointed sleep technology innovator Dr Andrew Tucker director of research and development.
Melbourne innovation and technology company Sleeptite has appointed sleep health and medical technology device expert Dr Andrew Tucker director of research and development.
He will be responsible for overseeing all aspects of non-invasive aged care monitoring and fall prevention system REMi, including product development, research and field trials, and leading its commercialisation.
Dr Tucker has over 17 years of experience in institutional research and development, industry innovation and commercialisation in the areas of sleep health, wellbeing and occupational safety.
He has a PhD in psychophysiology and works an adjunct senior lecturer at Monash University’s Turner Institute for Brain and Mental Health.
Prior to Sleeptite, he was the inaugural director of the Australian Sleep and Alertness Consortium, the research and development division of the Sleep Health Foundation.
There he led the establishment of ASAC to build upon the outputs, expertise and legacy of the federally-funded Cooperative Research Centre for Alertness, Safety and Productivity.
Dr Tucker’s new role includes leading a cross-functional team of hardware and software developers, electronics engineers and manufacturers.
Dr Tucker said he was excited to be joining the team.
“It is a privilege to be joining Sleeptite and to be leading the commercialisation of REMi – a ground-breaking innovation that I know will make a real difference in people’s lives,” Dr Tucker said.
Sleeptite CEO Cameron van den Dungen called Dr Tucker’s appointment a boost for the company.
“Being able to attract someone of the calibre of Andy to Sleeptite speaks volumes about the REMi system and what we as a company are aiming to achieve,” Mr van den Dungen said.
Have we missed an appointment or resignation? Send us the details and an image to editorial@australianageingagenda.com.au
